What is ICU Medical, Inc.'s (ICUI) StockRank?

MoatMap's StockRank for ICU Medical, Inc. (ICUI) is 82/100, with a Strong Buy signal. This is a composite score combining Quality (54), Value (48), and Momentum (74) factor ranks across MoatMap's 20,000+ stock universe.

Does ICU Medical, Inc. have an economic moat?

ICU Medical, Inc. (ICUI) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is ICU Medical, Inc. a buy, hold, or sell?

MoatMap's current signal for ICU Medical, Inc. (ICUI) is Strong Buy, based on a StockRank of 82/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is ICU Medical, Inc. in?

ICU Medical, Inc. (ICUI) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

ICUI

STRONG BUYFLAG

ICU Medical, Inc. · Healthcare · United States · $3.9B · Avg Vol: $47M/d

StockRank

Get insider-trade alerts

P/E (TTM)

84.6x

ROE

2.3%

D/E

0.6x

Dividend %

—

AI CONVICTION THESIS

ICU Medical has strong momentum M70 and quality Q53, but value at V48 is below the calibrated floor, and insiders sold, so stage one fails.

COMPANY DESCRIPTION

ICU Medical, Inc. is a medical technology company specializing in the development, manufacture, and sale of innovative medical devices and software for infusion therapy and critical care. The company's portfolio, including IV sets, pumps, and safety devices, addresses crucial needs in high-acuity environments, establishing high switching costs for healthcare providers. Its commitment to patient safety and clinical outcomes reinforces its strong market position within this essential healthcare niche.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	2.3B	2.3B	2.4B	2.2B	-0.7%	2.2B	2.2B	2.3B	1.3%
EPS	-3.11	-1.23	-4.83	0.03	—	1.86	0.03	0.04	9.7%
Shares	24.0M	24.1M	24.5M	24.7M	+2.9%	25.0M	—	—	—
Debt	1.7B	1.7B	1.6B	1.3B	-8.4%	1.3B	—	—	—
Equity	2.1B	2.1B	2.0B	2.1B	0.5%	—	—	—	—
Op CF	-62.1M	166.2M	204.0M	179.8M	4.0%	167.4M	—	—	—
Inv CF	-1.9B	-87.9M	-89.0M	122.2M	—	—	—	—	—
Fin CF	1.6B	-36.0M	-55.8M	-311.5M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+10.2%

SMA 50SMA 200

$157.44

RSI (14)

47.8

52W High

$162.85

From 52W High

1.0%

SCORE BREAKDOWN

Quality

ROIC

2.8%51.4

ROE

2.3%50.2

GP/Assets

20.2%48.5

Op. Margin

5.7%57.8

FCF/Assets

9.6%85.6

Piotroski

668.2

Int. Cover

1.0x40.1

D/E Ratio

0.64x25.2

Current Ratio

2.34x44.5

Value

P/E (TTM)

84.6x11.2

EV/EBITDA

16.0x41.4

P/FCF

10.2x82.3

P/B

1.9x62.9

P/S

1.8x70.5

Div Yield

—N/A

Momentum

52W High %

97%96.0

RS 6M

-9%64.4

SMA 50/200

1.04x72.5

EPS Rev 4W

+0.3%81.4

EPS Rev 12W

+1.6%69.2

EPS Improve

+402%94.7

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$3.9B

P/E (Forward)

16.9x

Gross Margin

37.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ICUI are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
ICUI	ICU Medical, Inc.(you)	$3.9B	82	STRONG BUY
MMSI	Merit Medical Systems, Inc.	$4.4B	78	BUY
NVST	Envista Holdings Corporation	$4.3B	89	STRONG BUY
XRAY	DENTSPLY SIRONA Inc.	$2.6B	73	BUY
LMAT	LeMaitre Vascular, Inc.	$2.2B	75	BUY
TFX	Teleflex Incorporated	$5.8B	70	BUY
ATR	AptarGroup, Inc.	$8.4B	74	BUY
SOLV	Solventum Corporation	$13.5B	78	BUY
ALGN	Align Technology, Inc.	$12.0B	93	STRONG BUY
AVTR	Avantor, Inc.	$7.8B	62	HOLD

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.7%